Nanoform Finland Plc (NANOFH.HE) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Finland · ISIN FI4000330972
Nanoform Finland Plc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.78 m EUR | 3.55 m EUR |
| Gross profit | 2.23 m EUR | -14.89 m EUR |
| Operating income | -24.24 m EUR | -22.25 m EUR |
| EBIT | -23.36 m EUR | -22.25 m EUR |
| Net income | -23.43 m EUR | -17.90 m EUR |
| Diluted EPS – continuing operations | -0.28 EUR | -0.21 EUR |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Nanoform Finland Plc
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and dosage forms of Nanoparticles. It also offers STARMAP, an AI platform predicts the performance of your molecule in Nanoform's technology. The company was founded in 2008 and is headquartered in Helsinki, Finland.
More stocks
- PT Cerestar Indonesia Tbk (TRGU.JK)
- Jayjun Co Ltd (025620.KS)
- Kyobo 10 Special Purpose Acquisition Co. (355150.KQ)
- TOPTEC Co. Ltd (108230.KQ)
- Lebledor F&B Co., Ltd. (7757.TWO)
- CANTOURAGE GROUP SE O.N. (HIGH.F)
- MARX Biotech Co., Ltd. (7731.TWO)
- LION COPPER & GOLD CORP. (LCGMF)
- TECOGEN INC. (TGEN)
- Evertex Fabrinology Ltd (1470.TW)
- Lumir Inc. (474170.KQ)
- Midnight Sun Mining Corp (MMA.V)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.